對抗 COVID19
23.85k 個跟隨者 • 14 個股票代號 追蹤清單由 TREA 提供
跟隨此名單即可探索和追蹤具有 COVID-19 相關治療和保健計劃之上市公司的股票。
策劃人： TREA
表現
| 追蹤清單 | 今日股價變化 | 1 個月回報 | 1 年回報 | 總回報 |
|---|---|---|---|---|
| 對抗 COVID19 | -0.72% | - | - | - |
| ^GSPC | +0.00% | +1.08% | +30.39% | +6262.48% |
14 個股票代號
| 代號 | 公司名稱 | 收市價 | 變化 | % 變化 | 市場時間 | 成交量 | 平均成交量 (3 個月) | 市值 |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 153.11 | +0.11 | +0.07% | 下午4:00 [EST] | 7.59M | 6.34M | 368.63B |
| ABBV | AbbVie Inc. | 167.76 | +1.19 | +0.71% | 下午4:00 [EST] | 3.02M | 5.41M | 296.46B |
| PFE | Pfizer Inc. | 24.94 | -0.16 | -0.64% | 下午4:00 [EST] | 40.57M | 36.46M | 141.33B |
| SNY | Sanofi | 47.78 | -0.22 | -0.46% | 下午4:00 [EST] | 1.25M | 1.88M | 121.14B |
| GILD | Gilead Sciences, Inc. | 88.63 | +0.88 | +1.00% | 下午4:00 [EST] | 4.55M | 6.73M | 110.46B |
| REGN | Regeneron Pharmaceuticals, Inc. | 743.35 | -1.25 | -0.17% | 下午4:00 [EST] | 654.42k | 693.24k | 81.69B |
| GSK | GSK plc | 33.35 | -0.11 | -0.33% | 下午4:00 [EST] | 7.17M | 5.64M | 68.04B |
| TAK | Takeda Pharmaceutical Company Limited | 13.29 | -0.33 | -2.42% | 下午4:00 [EST] | 3.78M | 1.72M | 42.84B |
| BNTX | BioNTech SE | 102.14 | -4.26 | -4.00% | 下午4:00 [EST] | 1.12M | 1.08M | 24.49B |
| MRNA | Moderna, Inc. | 36.94 | -0.35 | -0.94% | 下午4:00 [EST] | 7.31M | 6.48M | 14.22B |
| NVAX | Novavax, Inc. | 8.06 | +0.06 | +0.75% | 下午4:00 [EST] | 3.46M | 6.37M | 1.29B |
| VIR | Vir Biotechnology, Inc. | 6.74 | -0.19 | -2.74% | 下午4:00 [EST] | 1.47M | 987.97k | 928.23M |
| INO | Inovio Pharmaceuticals, Inc. | 3.97 | -0.06 | -1.49% | 下午4:00 [EST] | 423.04k | 320.30k | 103.62M |
Pharmaceutical TechnologyEC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia
The authorisation extends to all 27 EU member states, along with Liechtenstein, Iceland and Norway.
Motley Fool2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
High-yielding stocks can be due for cuts to their payouts if a company's underlying financials aren't strong enough to support its dividend payments. Two good examples of stocks that pay more than 6% and can still be ideal long-term options for retirees are Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ). A bearish outlook for the future has resulted in Pfizer's stock price tumbling more than 10% this year, despite what has generally been a strong year for the markets.
Zacks5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
These five laggards of this year have double-digit upside left for the rest of 2024. These are: ADBE, PFE, DG, SNAP, RYAAY.